https://doi.org/10.4081/monaldi.2013.30

Roflumilast succeeds where traditional therapy fails: a case report

Vol. 79 No. 3-4 (2013): Pulmonary series - Supplement 1
Submitted: August 19, 2015
Accepted: August 19, 2015
Published: August 19, 2015
Roflumilast, COPD, Case report
Abstract Views: 665
PDF: 596
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Gabriella Guarnieri
gabriella.guarnieri@unipd.it
Occupational Medicine, Respiratory Pathophysiology Laboratory; Department of Cardiologic, Thoracic and Vascular Sciences, University of Padova, Padova, Italy.
The case of a 72-year-old man with a long history of chronic obstructive pulmonary disease (COPD, patient D according to Guidelines GOLD 2013) in a subject professionally exposed to welding fumes is presented. Diagnosis was based on symptoms and spirometry and confirmed by chest X-ray examination. Since 1997 the patient has been under different therapies, including high-dose inhaled corticosteroids and bronchodilators, with poor clinical control and frequent exacerbations. Roflumilast 500 μg once daily was started in January 2012 and patient’s respiratory symptoms, number of exacerbations and spirometry values have gradually improved since then. Roflumilast was an effective treatment in this case of difficult to treat severe COPD.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC

How to Cite

Guarnieri, Gabriella. 2015. “Roflumilast Succeeds Where Traditional Therapy Fails: A Case Report”. Monaldi Archives for Chest Disease 79 (3-4). https://doi.org/10.4081/monaldi.2013.30.

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.